Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP842625.RAAwgyEsE54IHEQ2VV_kIWMX-PvweC3Pde9cElS32UD58130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP842625.RAAwgyEsE54IHEQ2VV_kIWMX-PvweC3Pde9cElS32UD58130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP842625.RAAwgyEsE54IHEQ2VV_kIWMX-PvweC3Pde9cElS32UD58130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP842625.RAAwgyEsE54IHEQ2VV_kIWMX-PvweC3Pde9cElS32UD58130_provenance.
- NP842625.RAAwgyEsE54IHEQ2VV_kIWMX-PvweC3Pde9cElS32UD58130_assertion description "[The proteins that were overexpressed are cancer inhibitors (NME, DRG1, IL10), enhancers (SOD2, FAK, IL17, and CREB), and proteins that suppress cancer progression in cells of some cancers and promote it in others (FUT1, integrin beta3, serpin E1, TIAM1, and claudin 4).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP842625.RAAwgyEsE54IHEQ2VV_kIWMX-PvweC3Pde9cElS32UD58130_provenance.
- NP842625.RAAwgyEsE54IHEQ2VV_kIWMX-PvweC3Pde9cElS32UD58130_assertion evidence source_evidence_literature NP842625.RAAwgyEsE54IHEQ2VV_kIWMX-PvweC3Pde9cElS32UD58130_provenance.
- NP842625.RAAwgyEsE54IHEQ2VV_kIWMX-PvweC3Pde9cElS32UD58130_assertion SIO_000772 21344390 NP842625.RAAwgyEsE54IHEQ2VV_kIWMX-PvweC3Pde9cElS32UD58130_provenance.
- NP842625.RAAwgyEsE54IHEQ2VV_kIWMX-PvweC3Pde9cElS32UD58130_assertion wasDerivedFrom befree-20150227 NP842625.RAAwgyEsE54IHEQ2VV_kIWMX-PvweC3Pde9cElS32UD58130_provenance.
- NP842625.RAAwgyEsE54IHEQ2VV_kIWMX-PvweC3Pde9cElS32UD58130_assertion wasGeneratedBy ECO_0000203 NP842625.RAAwgyEsE54IHEQ2VV_kIWMX-PvweC3Pde9cElS32UD58130_provenance.
- befree-20150227 importedOn "2015-02-27" NP842625.RAAwgyEsE54IHEQ2VV_kIWMX-PvweC3Pde9cElS32UD58130_provenance.